Skip to content
10-Q

Quarterly Report

Elanco Animal Health Incorporated ELAN

0001739104-26-000030

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 499.45M sh
Shares Diluted Q1 2026 · Mar 31, 2026 506M sh
Shares Diluted Q1 2026 · Mar 31, 2025 499.1M sh
Capex Q1 2026 · Mar 31, 2026 $51M
Capex Q1 2026 · Mar 31, 2025 $65M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $13M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $428M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $545M
Stockholders Equity Q1 2026 · Mar 31, 2026 $6.5B
Stockholders Equity Q1 2026 · Dec 31, 2025 $6.55B
Stockholders Equity Q1 2026 · Mar 31, 2025 $6.35B
Stockholders Equity Q1 2026 · Dec 31, 2024 $6.1B
Current Liabilities Q1 2026 · Mar 31, 2026 $1.66B
Current Liabilities Q1 2026 · Dec 31, 2025 $1.6B
Total Liabilities Q1 2026 · Mar 31, 2026 $6.72B
Total Liabilities Q1 2026 · Dec 31, 2025 $6.81B
Current Assets Q1 2026 · Mar 31, 2026 $3.58B
Current Assets Q1 2026 · Dec 31, 2025 $3.46B
Total Assets Q1 2026 · Mar 31, 2026 $13.22B
Total Assets Q1 2026 · Dec 31, 2025 $13.36B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.11
Eps Diluted Q1 2026 · Mar 31, 2025 $0.13
Eps Basic Q1 2026 · Mar 31, 2026 $0.11
Eps Basic Q1 2026 · Mar 31, 2025 $0.14
Sga Expense Q1 2026 · Mar 31, 2026 $381M
Sga Expense Q1 2026 · Mar 31, 2025 $341M
Rd Expense Q1 2026 · Mar 31, 2026 $97M
Rd Expense Q1 2026 · Mar 31, 2025 $94M
Net Income Q1 2026 · Mar 31, 2026 $57M
Net Income Q1 2026 · Mar 31, 2025 $67M
Gross Profit Q1 2026 · Mar 31, 2026 $785M
Gross Profit Q1 2026 · Mar 31, 2025 $684M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $586M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $509M
Revenue Q1 2026 · Mar 31, 2026 $1.37B
Revenue Q1 2026 · Mar 31, 2025 $1.19B